Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Nathan Bartlett, Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle

Omicron-specific vaccines may give slightly better COVID protection – but getting boosted promptly is the best bet

Vaccines (predominantly mRNA vaccines) have been our front-line defence against COVID and have saved millions of lives.

Despite the emergence of genetically distinct COVID variants throughout the pandemic, we’ve relied on vaccines that target the spike protein from the virus originally detected in Wuhan, China. While still providing excellent protection, mRNA vaccines are less effective against newer variants with immunity waning within months of immunisation.

Australia’s Omicron bivalent (two-strain) COVID vaccine has been approved for use and will be rolled out as stocks of the original vaccines need replacing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.